KIWITA
← Back to Evidence

For New Product Development and R&D reference only. Not intended for consumers.

Crystal UMO® for Health

Human, animal and pet tests for liver, blood pressure, bone and vessels, immunity and odor.

Core Results

Control = 100

Evidence Highlight

Fatty Liver: Human Clinical Trial

Human
Subjects40 patients with non-alcoholic fatty liver disease (NAFLD)
HospitalAichi Medical University Hospital
DesignRandomized | placebo | two groups
DoseUMO® Silica 9 mL daily (about 40 mg of silicon) | control: none
LifestyleBoth groups kept regular diet and exercise
Check pointsBefore | 3 months | 6 months
Body measurements
Blood chemistry
UMO® n = 16 | control n = 9 | one small trial
Terms
Lifestyle diseasesObesity, high blood pressure, diabetes, high blood fats.
Randomized controlled trialSubjects randomly split into two groups; one of the most reliable human study types.
Add-on effectThe extra improvement from UMO® on top of diet and exercise.
UMO® groupControl group
Weight
↓ 3 kgAverage weight loss, 6 months
+0.3 kg−2.4 kgStart3 mo6 mo
3 mo: p = 0.0340 | 6 mo: p = 0.0091
BMIWeight (kg) ÷ height (m)². ↓ lower is better. BMI ≥ 25 = obese (Japan).
↓ 1.5kg/m²BMI (kg/m²) after 6 months
+0.3 kg/m²−0.9 kg/m²Start3 mo6 mo
3 mo: p = 0.0444 | 6 mo: p = 0.0024
WaistFat around the organs, most linked to fatty liver. ↓ lower is better.
↓ 3 cmWaist, 6 months
+0.6 cm−2.6 cmStart3 mo6 mo
6 mo: p = 0.0021
PAI-1Makes blood clots harder to dissolve; rises with visceral fat. ↓ lower is better.
↓ 10ng/mLPAI-1 (ng/mL) after 6 months
+4.2 ng/mL−6.3 ng/mLStart3 mo6 mo
6 mo: p = 0.0425
ChEReflects the liver's ability to make protein and process fat.
↓ 35U/LChE (U/L), significant
+9.0 U/L−27.0 U/LStart3 mo6 mo
6 mo: p = 0.0472
ASTLiver marker that rises when liver cells are damaged. ↓ lower is better.
↓ 15U/LAST (U/L), trend only
+5.0 U/L−15.0 U/LStart3 mo6 mo
6 mo: p = 0.059
AdiponectinA hormone from fat cells. ↑ Higher is better.
No changeUMO® group stayed level | control fell at 3 mo (µg/mL)
−0.8 µg/mL−0.1 µg/mLStart3 mo6 mo
3 mo: p = 0.0295
Change from start | ≈ read from chart | lines connect group means
ItemControlUMO®p (UMO®)
Body weightn.s.↓ sig. 3 & 6 mo (≈ 3 kg)0.0340 (3 mo), 0.0091 (6 mo)
BMIn.s.↓ sig. 3 & 6 mo0.0444, 0.0024
Waistn.s.↓ sig. 6 mo (3 cm)0.0021
Visceral fat area↑ n.s.↓ n.s.—
PAI-1n.s.↓ sig. 6 mo (10 ng/mL)0.0425
Adiponectin↓ sig. 3 moNo change0.0295 (control drop)
ChEn.s.sig. 6 mo (↓ 35 U/L)0.0472
ASTn.s.trend 6 mo (↓ 15 U/L)0.059
Blood fats, sugar, ALT, γ-GTPn.s.n.s.—
QOL (SF-8)n.s.n.s.—
Side effectsNoneNone—
sig. = p < 0.05 | n.s. = not significant | 40 randomized → 25 analysed
Lifestyle disease + fatty liver | RCT | UMO® ≈ 9 mL/day + diet & exercise | UMO® n = 16 | control n = 9 | 6 months
Aichi Medical University Hospital
Fukuzawa, Y., Okada, K., & Jimbo, D. (2022).Usefulness of Water Soluble Silicon for Fatty Liver Combined with Lifestyle Related Disease. Aichi Medical University Hospital.
Full paper: Fatty Liver Trial →

Blood Pressure and Stress: Human Pilot Study

Human
Subjects12 people with pre-hypertension
average age 41.08 ± 1.73 years
DesignPilot study | no control group
DoseUMO® water-soluble silica 9 mL daily (40 mg silicon)
Duration6 weeks
SourceShinbo, T. (January 2024)
No adverse events
Terms
Accelerated plethysmographyA fingertip device records the pulse wave to show autonomic nerve state.
Autonomic nervesAutomatic control of heart rate, blood pressure and digestion; sympathetic (alert) and parasympathetic (relax).
Salivary cortisol / sIgAA stress hormone and an immunity-linked antibody, from saliva.
eGFRKidney filtering ability.
Wilcoxon signed-rank testCompares the same people before and after; p < 0.05 = significant.
SystolicThe "upper" (heart pumps) and "lower" (heart relaxes) numbers. For people with high values ↓ is better.
↓ 10.4mmHgSystolic blood pressure, mmHg, 6 weeks
118.9 mmHg129.3BeforeAfter 6 wk
DiastolicThe "upper" (heart pumps) and "lower" (heart relaxes) numbers. For people with high values ↓ is better.
↓ 5.9mmHgDiastolic blood pressure, mmHg, 6 weeks
75.7 mmHg81.6BeforeAfter 6 wk
Holmes magnitudeA questionnaire rating recent stress. ↓ lower is better.
↓ 36.6Holmes magnitude, score, 6 weeks
12.449.0BeforeAfter 6 wk
Holmes totalA questionnaire rating recent stress. ↓ lower is better.
↓ 35.6Holmes total, score, 6 weeks
36.171.7BeforeAfter 6 wk
SDNNVariation in time between heartbeats; overall autonomic activity.
↓ 13.1msSDNN, ms, 6 weeks
40.6 ms53.7BeforeAfter 6 wk
PSIPhysical stress index; ↓ lower is better per the report.
↑ 4.8PSI, index, 6 weeks
62.157.3BeforeAfter 6 wk
Before → after 6 weeks | ≈ read from chart | n = 12
Felt after drinking% of subjects
More energetic
≈ 58.3%
Better blood pressure
≈ 50.0%
Better motivation & focus
≈ 41.7%
Wake up refreshed
≈ 33.3%
Less shoulder stiffness
≈ 33.3%
Less cold hands & feet
≈ 25.0%
Less fatigue
≈ 16.7%
Better skin
≈ 16.7%
Weight loss
≈ 8.3%
Less swelling
≈ 8.3%
0%10%20%30%40%50%60%70%
Subjective | ≈ = read from chart | n = 12
Before → after 6 weeksResult
Systolic↓ sig.  |  ≈ 129.3 → ≈ 118.9
Diastolic↓ sig.  |  ≈ 81.6 → ≈ 75.7
Holmes stress, Holmes total↓ sig.  |  ≈ 49.0 → ≈ 12.4  |  ≈ 71.7 → ≈ 36.1
Fatigue VAS, OSA sleepn.s.
SDNN (autonomic)↓ sig.  |  ≈ 53.7 → ≈ 40.6
PSI (physical stress)↑ sig. (more physical tiredness)
Blood testsSmall sig. changes, within normal range
Adverse events, dropouts0  |  0
≈ = read from chart | sig. = P < 0.05 | ethics No. 20230915-1
Healthy adults 20–64 (pre-hypertension, mean age 41.1 ± 1.7) | Single group, no control | UMO® ≈ 9 mL/day (3 mL × 3) | n = 12 | 6 weeks | Wilcoxon
Tottori University
Shinbo, T. (January 2024). Improvement of blood pressure and stress reduction through ingestion of UMO water-soluble silicon. Visiting Professor, Faculty of Medicine, Tottori University.Jimbo, T., & Okada, K. (2023). Improvement of Blood Pressure When Water-Soluble Silicon Is Ingested.
Full paper: Blood Pressure and Stress →

Customer Testimonial: Capillary Blood Flow

Human | testimonial
SubjectOne customer | n not stated
DoseCrystal UMO® 40 mg
Duration3 months
MethodNailfold capillaroscopy
A customer record, not a controlled test
Capillary blood flowBefore / After
Human testimonial | Fingertip photosCrystal UMO® 40 mg | 3 months
Nailfold capillaries before taking UMO
Before
Nailfold capillaries after taking UMO 40 mg for 3 months
After
Tateda, M., Kaneko, S., & Okada, K. (Eds.). (2025). Testimonial Collection: Silicon (Silica) Lighting the Way for Intractable Diseases: Records of Doctors, Patients, and Families.
Source: Testimonial Collection →

Silicon and Collagen

Reference | not a UMO test
Silicon
↓
Fibroblasts
collagen-making cells
↓
Procollagen ↑
↓
Type I & III collagen ↑
Collagen28 types
Collagen types in the body (I–XXVIII)
TypeWhereRoleShare
Type ISkin, bone, tendon, teethMost abundant, strength≈ 90%
Type IICartilage, eye vitreousJoint flexibility≈ 1%–2%
Type IIISkin, vessel walls, organsWith Type I, elasticity≈ 8%
Type IVBasement membraneCell attachment, barrier< 1%
Type VPlacenta, hair, skinType I fiber control< 1%
Type VIAround muscle, skinECM network< 1%
Most direct benefit: skin | vessels | bone
Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HF, Evans BA, Thompson RP, Powell JJ, Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003 Feb;32(2):127-35.Geesin JC, Darr D, Kaufman R, Murad S, Pinnell SR. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblasts. J Invest Dermatol. 1988 Apr;90(4):420–424. (this paper is about vitamin C)
References | not UMO tests →

Framingham Offspring Study

Reference | not a UMO test
SubjectsHuman | n = 2,847
IntakeDietary silicon > 40 vs < 14 mg/day
MethodDietary silicon vs bone mineral density
A study on dietary silicon
Bone density
↑ 10%Si > 40 vs < 14 mg/day
1.081.000.920.841020304050(g/cm²)Bone mineraldensitySilicon intake (mg/day)MenPremenopausal womenPostmenopausal women
Jugdaohsingh, R., et al. (2004). Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. Journal of Bone and Mineral Research, 19(2), 297–307.
Reference →

Silicon: The Cross-Linker of Bone and Skin

Reference | not a UMO test
Silicon links collagen chains
↓
Collagen holds calcium in place
↓
Denser, less brittle bone
Cross-linkerSilicon
Silicon links collagen chains together.
ConcreteCalciumRebarCollagenCross-linkerSilicon
Reffitt et al., 2003. Orthosilicic acid stimulates collagen type I synthesis and osteoblastic differentiation in vitro. Bone.Carlisle, 1986. Silicon as an essential trace element in animal nutrition. Ciba Foundation Symposium.
References | not UMO tests →

Rat Bone Strength and Vessel Elasticity

Animal | rat
SubjectsWistar rat, male, 10 wk | n = 3–4
GroupsControl (tap water) | UMO® 10%
Rare sugar | UMO® + rare sugar
Dose10% in water
Duration50 days | tensile test
Animal data, not human
Terms
Tensile testA bone or vessel is pulled until it breaks, measuring force and stretch.
Radius, ulna / humerus / femur, tibiaForearm / upper arm / thigh and shin bones.
Rare sugarA sugar found in very small amounts in nature; tested as a separate group.
Vessel max strainHow far a vessel stretches before breaking. ↑ higher = more elastic.
↑ 151.3%Vessel max strain vs control
00.511.520.427±0.155n = 3Control1.073±0.336n = 3UMO® 10%1.131±0.17n = 3Rare sugar1.758±0.365n = 3UMO® + rare sugarp = 0.0391p = 0.0171p = 0.0044Strain to the max stress
p = 0.0391
Radius rupture stressMax force per area before breaking. ↑ higher = stronger.
↑ 54.3%Radius rupture stress vs control
200300400500600700288.484±56.877n = 6Control445.089±78.301n = 6UMO® 10%371.319±28.136n = 6Rare sugar487.712±142.953n = 8UMO® + rare sugarp = 0.0039p = 0.0076p = 0.0095Rupture stress σf (N/mm²)
p = 0.0039
vs control (tap water)UMO® 10%UMO® + rare sugar (10% each)
Vessel max strain↑ p = 0.0391↑ p = 0.0044
Radius stress↑ p = 0.0039↑ p = 0.0095
Ulna + radius stressn.s. (p = 0.1752)↑ p < 10⁻⁴
Humerus stress↑ trend (p = 0.0956)↑ p = 0.0135
Femur, tibia stressn.s.n.s.
Radius diameter↓ p < 10⁻⁶↓ p = 0.0037
n.s. = not significant | trend = p < 0.1
Kawamura, Y., Yokota, Y., Nogata, F., Terasawa, M., Kamijo, T., & Okada, K. (2014, May).Analysis of Stress-Strain of Rat's Bone and Blood Vessel with Dietary Silicon Intake. IEICE Technical Report, MBE2014-7.
Full paper: Rat Bone and Vessel →

Immune Function in Rats

Animal | rat
SubjectsWistar rat, male, 15 wk
DoseUMO® 1% in water
Duration58 days (n = 4) | 70 days (n = 5)
Source2013 | no significance test
A small animal study
Terms
ThymusIn the chest; trains T cells; shrinks with age.
SpleenUpper left belly; stores lymphocytes and filters blood.
Wistar ratsA common lab rat strain.
Lymphocyte count, 58 daysWhite blood cells that find and attack bacteria, viruses and abnormal cells. ↑ more = better defense.
↑ 86.5%Thymus lymphocytes, UMO® 1% vs water
↑ 36.6%Spleen lymphocytes, UMO® 1% vs water
6.97
Thymus control
13.0
Thymus UMO®
2.16
Spleen control
2.95
Spleen UMO®
58 days, million cells
no significance test
Lymphocyte count, 70 daysWhite blood cells that find and attack bacteria, viruses and abnormal cells. ↑ more = better defense.
↑ 77.4%Thymus lymphocytes, UMO® 1% vs water
↑ 48.0%Spleen lymphocytes, UMO® 1% vs water
3.36
Thymus control
5.96
Thymus UMO®
3.48
Spleen control
5.15
Spleen UMO®
70 days, million cells
no significance test
Mean lymphocyte count | million cells | Mean ± s.d. as printed
OrganGroup58 days70 days
SpleenWater2.16M ± 0.45M3.48M ± 1.52M
UMO® 1%2.95M ± 1.31M (↑ 36.6%)5.15M ± 1.36M (↑ 48.0%)
ThymusWater6.97M ± 2.70M3.36M ± 1.79M
UMO® 1%13.0M ± 5.45M (↑ 86.5%)5.96M ± 2.72M (↑ 77.4%)
Mean ± s.d. as printed
Terasawa, M., Okada, K., & Sugahara, A. (2013).Effects of water-soluble silicon (umo) on the immune function in rats. Journal of Health and Medical Research, (5). Japan Society of Health and Medical Sciences.
Full paper: Immune Function →

Nail Minerals and Heavy Metals: Observation Test (n = 1)

Human | n = 1
Subject1 healthy man, 50s | n = 1
DoseUMO® 4 mL/day
2020-03-13 → 2020-12-04
MethodXRF (Rigaku NEX CG)
Toshiba Nanoanalysis
PeriodNails 2020-01 → 2022-11
Terms
X-ray fluorescence (XRF)X-rays make each element give a different signal; many elements at once. Semi-quantitative, so numbers are rough.
Mass ppmWeight concentration; 150 ppm = about 150 mg silicon per kg of nail.
Semi-quantitative analysisShows ups and downs, not calibrated with standards.
n = 1One person, no control; results cannot be applied to people in general.
10 repeat measurementsShows instrument error, not differences between people.
Silicon ↑, Aluminum ↓OligoScan analysis of minerals and heavy metals in the body showed silicon deficiency and aluminum build-up.Silicon and aluminum are generally thought to be inversely related, like selenium and mercury.
Fingernail Si, average
+20.8%138 → 167 ppm (effect period avg)
138
Before intake
167 (+20.8%)
Effect period (avg)
162 (+17.5%)
8 months after stopping
Fingernail Si, ppm
Mass ppm | semi-quantitative XRF
Continuous Change in Silicon (Si) Level→ Significant increase, gradually building up in bone, vessels, hair and other tissues
Continuous Change in Silicon (Si) Level: nail element, mass ppm, 2020-01 to 2023-01
①12/July②9/Aug③15/Mar④2/DecCOVID-19 vaccination date
○ Hand | * Hand average | △ Feet | * Feet average
Continuous Change in Aluminum (Al) Level→ Significant drop. UMO® water-soluble silica binds aluminum ions (Al³⁺) to form an aluminum-silicate complex, which is then removed in urine, reducing deposits in tissues.
Continuous Change in Aluminum (Al) Level: nail element, mass ppm, 2020-01 to 2023-01
①12/July②9/Aug③15/Mar④2/DecCOVID-19 vaccination date
○ Hand | * Hand average | △ Feet | * Feet average
Continuous Change in Calcium (Ca) Level→ Significant increase. UMO® Silica gradually builds up in bone tissue, boosting collagen in the bone matrix and strengthening calcium binding and deposition.
Continuous Change in Calcium (Ca) Level: nail element, mass ppm, 2020-01 to 2023-01
①12/July②9/Aug③15/Mar④2/DecCOVID-19 vaccination date
○ Hand | * Hand average | △ Feet | * Feet average
Mass ppm | semi-quantitative XRF | Gifu University
Tokai National Higher Education and Research System, Gifu University
Yokota, Y. (2023, May 14).Changes in Elemental Content of Human Nails With Intake of Water-Soluble Silicon UMO [Conference presentation]. Japan Society of Silicon Medical Research Clinical Meeting. Gifu University, Tokai National Higher Education and Research System.
Full paper: Nail Elements →

Kidney Function and Safety

Animal | rat
SubjectsWistar rat, male, 7 wk | 13 rats
ModelAdenine-induced kidney damage
DoseUndiluted UMO®, daily oral
Duration28 days | 2021-03-01 → 04-30
SourceTest No. 21775
A small animal study
Terms
Adenine modelToo much adenine forms crystals in the kidneys, causing damage similar to CKD.
Urine creatinineA muscle waste product removed by the kidneys.
NOAELThe highest dose with no side effects.
Safety, UMO® only vs controlNOAEL: the highest dose with no side effects. A bigger number = a safer ingredient.
> 6 g/kgNOAEL, authors’ estimate (rats, 28 days)
No deaths, normal condition✓
Normal weight gain✓
Blood chemistry and cells: no clear difference✓
Urine volumeDamaged kidneys cannot concentrate urine, so volume ↑ means worse damage. ↓ a smaller rise is better.
≈ 5× → 4×
Adenine + water → adenine + UMO® (week 2 vs before)
Urine creatinineA muscle waste product; damaged kidneys give diluted urine, so it drops. A smaller drop = closer to normal.
≈ 1/6 → 1/4
Adenine + water → adenine + UMO® (week 2 vs before)
Urine phosphorusCreatinine-corrected. ↓ a smaller rise is better.
↓ 23%Adenine + UMO® vs adenine + water (week 4, trend)
05001,0001,5002,0002,500mg/g·CrePre14 Day28 Day≈ 800≈ 900≈ 1,750≈ 1,350
○ Control□ UMO® only● Adenine + water■ Adenine + UMO®
Why no burden on the kidneys?Two groups of rats: healthy ones, and ones with damaged kidneys.
✓  Healthy rats drinking UMO®: no change from normal (urine volume ≈ 1×, creatinine ≈ 1×)
✓  Damaged kidneys + UMO®: closer to normal (urine volume ≈ 5× → 4×, creatinine ≈ 1/6 → 1/4, phosphorus ↓ 23%)
Blood fats and liver markerγ-GTP is a liver marker; TG, T-CHO and PL are blood fats. ↓ lower is better.
↓ 23%γ-GTP
↓ 32%TG
↓ 14%T-CHO
↓ 13%PL
UMO® only vs control3–4 rats per group
≈ = as stated in the report | ↓ lower is better
ItemControlUMO® onlyAdenine + waterAdenine + UMO®
ConditionNormalNormalNo deathsNo deaths
Body weightNormal gainNormal gainNo gain after 2 wkNo gain after 2 wk
Urine volume≈ 1×≈ 1×≈ 5×≈ 4×
Urine creatinine≈ 1×≈ 1×≈ 1/6≈ 1/4
Urine phosphorus (wk 4)——HighHigh (↓ 23%)
γ-GTP / TG / T-CHO / PLBaseline↓ 23% / 32% / 14% / 13%——
Week 2 vs before | — = not described
APA Corporation. (2021).Renal Function and Safety Evaluation Study Using Adenine-Induced Kidney Damage Model Rats (Test No. 21775). Aitec Laboratory Co., Ltd.
Full paper: Kidney Function and Safety →

Antioxidant: Free Radical Scavenging

In vitro
MarkerFree radical scavenging
DoseUMO® 10× | 100× | 1000×
Superoxide ↓ + Hydroxyl radical ↓
↓
Oxidative damage ↓
↓
Oxidative aging ↓
Terms
Free radicalsUnstable molecules from metabolism and UV that damage cells and speed up ageing.
ESRDetects free-radical signals directly. Scavenging rate ↑ higher is better.
Superoxide O₂⁻The most common one; turns into stronger radicals.
↑ 85.0%Scavenging, UMO® 10×
85.0%
10×
65.5%
100×
12.5%
1000×
Superoxide O₂⁻ ↑
↑ better
Hydroxyl ·OHThe strongest oxidant; damages cells, proteins and DNA.
↑ 67.2%Scavenging, UMO® 10×
67.2%
10×
13.8%
100×
−3.9%
1000×
Hydroxyl ·OH ↑
↑ better
Singlet oxygen ¹O₂Formed when skin meets UV; causes photoageing.
↑ 17.2%Scavenging, UMO® 10×
17.2%
10×
1.9%
100×
–1000×
Singlet oxygen ¹O₂ ↑
↑ better
ROSShare in body10×100×1000×
Superoxide (O₂⁻)≈ 70–80%85.0%65.5%12.5%
Hydroxyl (·OH)≈ 5–10%67.2%13.8%−3.9% (no effect)
Singlet oxygen (¹O₂)≈ 1–3%17.2%1.9% (weak)–
↑ better | – = not in deck
Kanagawa Dental University
Taiichi Maeda, Chang-Il Lee, & Fumihiko Yoshino. (January 2014).Measurement of the Scavenging Ability of Water-Soluble Silicon "UMO®" Against Various Reactive Oxygen Species Using the Electron Spin Resonance (ESR) Method.Kanagawa Dental University Graduate School.
Full paper: Free Radical Scavenging →

Gut Health: Broiler Fecal Odor

Animal | broiler
SubjectsBroiler | n = 30
DoseUMO® 1% | 5% in water
Duration7 weeks (chart: "After 50 days")
2017-04
Animal data, not human
Fecal indoleMade when gut bacteria break down protein; a main source of fecal odor. ↓ lower is better.
≈ ↓ 16%UMO® 1% in water vs control
≈ ↓ 82%UMO® 5% in water vs control
≈ 0.61
Control
≈ 0.51
1%
≈ 0.11
5%
Indole, feces + urine, µg/g
≈ read from chart | feces + urine, µg/g
Yamamoto, J., et al. (2017).Beneficial effect of water-soluble silicon on the meat quality and fecal odor of broiler chickens. J. Vet. Med. (Tokyo), 70(4), 279–282.
Full paper: Broiler Manure Odor →

Pet: Bad Breath in Dogs

Pet | beagle dogs
Subjects5 beagle dogs | male & female
DoseUMO® 1% | 5% in water
Duration4 weeks (wk 2 & 4)
SourceAzabu University | APA Corporation (2018)
A small study | 5 dogs
Halitosis score
↓ 36%Halitosis score, 4 weeks, UMO® 5%
0123456Pre2 w4 w1%5%Halitosis score
Fig. 2 | mean ± SD, n = 5
Bacteria score
↓ 79%Bacteria score, 4 weeks, UMO® 5%
01234567***Pre2 w4 w1%5%Bacteria score
Fig. 4 | * p = 0.05
ScorePre2 w 1%2 w 5%4 w 1%4 w 5%Reported
Halitosis5.0 / 5.0≈ 4.8≈ 3.0≈ 4.6≈ 3.2↓ 8% (1%), ↓ 36% (5%)
Bacteria≈ 3.8 / ≈ 3.8≈ 3.1≈ 2.3≈ 3.1≈ 0.8 *↓ 18% (1%), ↓ 79% (5%)
≈ = read from chart | * sig. at 4 w (5%)
Azabu University
Azabu University and APA Corporation (2018).Study on the effect of water-soluble silicon on reducing bad breath in dogs. Azabu University Joint Research Report No. 2584, pp. 1–10.
Full paper: Dog Bad Breath →

Fecal Odor in Mice

Animal | mouse
SubjectsC57BL/6 male mice | n = 11–12
DietHigh-fat, 60% kcal lard
DoseUMO® 1% | 10% in water
Si 83.7 | 837 µg/mL
Duration7 weeks
Animal data, not human
Terms
High-fat diet60% of calories from lard, to mimic obesity and fatty liver.
Fecal indoleMade when gut bacteria break down protein; a main source of fecal odor. ↓ lower is better.
≈ 2× → 1×High-fat diet doubled indole; UMO® 1% & 10% brought it back near normal feed
3.9
Normal feed
7.7
High-fat + tap
4.8
High-fat + UMO® 1%
3.8
High-fat + UMO® 10%
Indole, ng/mg feces
UMO® vs high-fat + tap: p < 0.05 | n = 11–12
Note | Both UMO® groups drank less water (authors: silicon’s bitter taste)
Sugita, K., Kawai, A., Shirai, M., Takagi, Y., Goto, S., & Asai, F. (2015).Effect of Water-soluble Silicon on Liver Damage and Fecal Odor in High-fat Diet-fed Mice. Journal of Veterinary Medicine (Juui Chikusan Shinpo), 68(11), 843–847.
Full paper: Fecal Odor in Mice →

Safety Checks

Test Reports & Certification

Made from natural quartz, but after the patented process it is no longer crystalline.

XRD test✓
No cristobaliteNot found ✓
XRD test✓
No tridymiteNot found ✓
GLP study✓
NegativeNo cell toxicity, no gene mutation ✓
PFAS test✓
Not detectedPFOS, PFOA, PFHxS, PFNA ✓
·X-ray diffraction (XRD) identifies crystal structure. UMO is 100% non-crystalline silicon.
·The safety study under Good Laboratory Practice (GLP) found no genotoxic risk, in both the screening test and the main study.
·Four PFAS compounds (PFOS, PFOA, PFHxS, PFNA) were not detected in the UMO concentrated solution raw material. Limit of quantification: 20 ng/kg.
Test reports
Non-crystalline siliconXRD testNon-crystalline silicon
No genotoxic riskGLP studyNo genotoxic risk
PFAS test (Shokukanken)2 Oct 2026PFAS test (Shokukanken)
Silicic acid 1.80% (JFRL)15 Oct 2026Silicic acid 1.80% (JFRL)
Anti-doping analysis reportAnti-dopingNo active substance
Certificates
Halal (NAHA) Halal (NAHA)
JHNFA GMP, dietary supplementsValid to 2 Jul 2029JHNFA GMP, dietary supplements
MAFF GHP and HACCPValid to 24 Aug 2029MAFF GHP and HACCP
INCI name registration (PCPC)19 Sep 2022INCI name registration (PCPC)
·Halal certified by the Nippon Asia Halal Association. Indonesia’s BPJPH recognises NAHA certificates, with the same legal effect for cross-border clearance and sales.
·Made at APA Corporation’s Aichi factory, certified under JHNFA GMP and by Japan’s Ministry of Agriculture, Forestry and Fisheries (MAFF) for hygiene and HACCP.
·The INCI letter registers the name Hydrated Silica. It is not a safety approval.

Bring UMO® to Your Product

Tell us what you make.
We reply with the right documents and samples.

Tell us what you need.

I would like to
This page presents research on the ingredient only.It does not make any claim about a finished product.Results come from the stated test conditions and may not apply to other products or individuals.KIWITA SDN. BHD. is not responsible for how the ingredient is used in any finished product or for any claims made about it.Terms & DisclaimerThe summaries on this page are prepared by KIWITA SDN. BHD. from third-party test reports and published studies. They are for reference only and are not medical, regulatory or professional advice.KIWITA has made reasonable efforts to summarise them accurately. KIWITA does not guarantee that the summaries, figures or translations are complete, current or free from error. If there is any difference, the original report prevails.Test results apply only to the stated samples and conditions. They are not a guarantee of performance, safety, efficacy or fitness for any product, market or use.You are responsible for checking the original reports and for meeting the laws and regulations of your market, including claims, labelling and registration.To the fullest extent permitted by law, KIWITA SDN. BHD. is not liable for any loss or damage arising from reliance on this page. Samples, specifications, quotations and prices are subject to a separate written agreement.